During the past decade, Piedmont Dialysis Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Piedmont Dialysis Center" are "COVID-19" (1 trials), "Calcific Uremic Arteriolopathy" (1 trials), "Calciphylaxis" (1 trials), "ESRD" (1 trials) and "End Stage Renal Disease" (1 trials). Many other conditions were trialed in "Piedmont Dialysis Center" in a lesser frequency.

Most popular intervention types in "Piedmont Dialysis Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Experimatenl SNF472 (Open-label)" (1 trials), "Experimental: SNF472" (1 trials), "PF-07321332 (nirmatrelvir)/ritonavir" (1 trials), "Placebo Comparator: Placebo" (1 trials) and "ferric citrate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Piedmont Dialysis Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Piedmont Dialysis Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Piedmont Dialysis Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Piedmont Dialysis Center, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".